United States Hereditary Genetic Testing Market Report

DUBLIN, Jan. 09, 2023 (GLOBE NEWSWIRE) — The “US Hereditary Genetic Testing Market: Focus on Product, Sample Type, Application Area, and Genetic Testing Type – Analysis and Forecast, 2022-2032” report has been added to ResearchAndMarkets.com’s offering. The US hereditary genetic testing market was valued at $7.57 billion in 2021 and is expected to grow with … Read more

Myriad Genetics Hires Five Senior Leaders to Advance

New leaders to elevate product portfolio, customer-centric commercial capabilities, and sales and marketing execution SALT LAKE CITY, Dec. 19, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the addition of five senior executives to help further strengthen the company’s product roadmap and improve commercial … Read more

NHS England Completes Move Towards Rapid Whole Genome Sequencing Of All Critically Ill Infants

Whole genomic sequencing is integral to the personalization of medicine. getty Precision medicine holds the potential to transform healthcare. From the year 2000, when President Clinton and Prime Minister Blair announced completion of the Human Genome Project, to the present, precision medicine has advanced to the point where it’s integral to clinical drug development. Equally … Read more

WellSpan Health and Helix announce partnership to improve

York, Pa., Dec. 08, 2022 (GLOBE NEWSWIRE) — WellSpan Health and Helix, the nation’s leading population genomics and viral surveillance company, announced today a partnership to create a comprehensive population genomics program designed to improve patient healthcare outcomes by integrating genetic insights into clinical care and research . Patients who are interested can have a … Read more

Rare Disease Genetic Testing Market Report 2022: Increased

Dublin, Nov. 30, 2022 (GLOBE NEWSWIRE) — The “Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Specialty; By Technology; By Disease Type; By End-Use; By Region; Segment Forecast , 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global rare disease genetic testing market size is expected to reach USD 2,414.90 … Read more

Genetic Testing Revealed Chris Hemsworth’s Alzheimer’s Risk & Here’s What It Can Tell You

Chris Hemsworth revealed some shocking news to his fans this month, saying he is taking a break from acting after finding out he has a high risk of Alzheimer’s disease. the Thor actor got the news after getting a genetic test done while filming his new Disney+ documentary series Limitless. In an interview with Vanity … Read more

United States Molecular Diagnostics Market Analysis Report 2022: A $12.5 Billion Market by 2027 – Industry Trends, Growth, Insights, Impact of COVID-19, Company Analysis – ResearchAndMarkets.com | Business & Finance

Country United States of AmericaUS Virgin IslandsUnited States Minor Outlying IslandsCanadaMexico, United Mexican StatesBahamas, Commonwealth of theCuba, Republic ofDominican RepublicHaiti, Republic ofJamaicaAfghanistanAlbania, People’s Socialist Republic ofAlgeria, People’s Democratic Republic ofAmerican SamoaAndorra, Principality ofAngola, Republic ofanguillaAntarctica (the territory South of 60 deg S)Antigua and BarbudaArgentina, Argentine RepublicArmeniaArubaAustralia, Commonwealth ofAustria, Republic ofAzerbaijan, Republic ofBahrain, Kingdom ofBangladesh, People’s … Read more

Should You Get Genetic Test Like Chris Hemsworth?

Share on PinterestActor Chris Hemsworth revealed that he has learned from a recent genetic test that he has a high Alzheimer’s risk. Photo by Lisa Maree Williams/Getty Images Chris Hemsworth has discovered he may be at a higher risk of developing Alzheimer’s disease. A genetic test revealed that Hemsworth has two copies of the APOE4 … Read more

Prostate Cancer Has High Rate of Actionable Mutations, Underscoring Need for Testing

All patients with prostate cancer, except for those with low-risk or very low-risk localized disease, should be tested for germline mutations, and somatic testing should be done in all patients with metastatic disease as there are therapeutic implications. All patients with prostate cancer, except for those with low-risk or very low-risk localized disease, should be … Read more

Genetic Testing Proves Significant in Identifying Somatic and Germline Mutations in Prostate Cancer

As the role of genetic testing in clinical practice becomes more prevalent for patients with prostate cancer to identify mutations, physicians must consider a variety of factors to determine which patients are candidates for somatic and/or germline testing. As the role of genetic testing in clinical practice becomes more prevalent for patients with prostate cancer … Read more